期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
腹腔镜下止血设备新进展 被引量:6
1
作者 Eric Lee WS Felix Wong +1 位作者 黄倩 应小燕 《中国微创外科杂志》 CSCD 2011年第5期385-390,共6页
目的为提高血管闭合性能、手术效果和临床结局,市场上研发了许多新式的血管闭合系统。在微创手术中,爆破压、横向热扩散、闭合率和故障率是选择器备并获得最理想手术效果的重要考虑参数。本文详细介绍多种新式止血设备的物理学原理和基... 目的为提高血管闭合性能、手术效果和临床结局,市场上研发了许多新式的血管闭合系统。在微创手术中,爆破压、横向热扩散、闭合率和故障率是选择器备并获得最理想手术效果的重要考虑参数。本文详细介绍多种新式止血设备的物理学原理和基本运行机制,并回顾相关文献评价各个设备的优缺点。 展开更多
关键词 血管闭合 止血设备 腹腔镜手术
下载PDF
通过腹腔镜子宫切除术(LH)和改良小切口经腹子宫切除术(MAH)切除巨大子宫的回顾性分析--子宫切除术手术路径的再评价 被引量:6
2
作者 Felix Wong Eric Lee 应小燕(翻译) 《中国微创外科杂志》 CSCD 2011年第4期289-294,共6页
腹腔镜子宫切除术(laparoscopic hysterectomy,LH)自1989年引入临床,已经成为除了传统的经腹子宫切除术(abdominal hysterectomy,AH)的广泛的可以接受的另一种选择。一些随机对照试验表明LH与AH相比有它的优点,如恢复快、疼痛轻、住院... 腹腔镜子宫切除术(laparoscopic hysterectomy,LH)自1989年引入临床,已经成为除了传统的经腹子宫切除术(abdominal hysterectomy,AH)的广泛的可以接受的另一种选择。一些随机对照试验表明LH与AH相比有它的优点,如恢复快、疼痛轻、住院时间短、近期生活质量高,而AH的优点在于手术时间短,若腹腔镜手术失败可作为一个后备的手术方案。通过对盆腔解剖有很好的了解而充分的术前评估,加之技术的成熟,作者(Felix Wong)用改良的小切口经腹子宫切除术(modified mini-laparotomy approach for abdominal hysterectomy,MAH)处理巨大子宫,体会在处理有潜在较复杂的病例中MAH可能更加适宜,如非常大的子宫平滑肌瘤或子宫重量超过500 g,尤其是当LH很难操作时或LH可能导致不适当的并发症时。在2006~2008年的回顾性分析中,MAH手术具有时间短、手术后止痛剂的使用少、术后感染率低的优点,尽管与LH相比,在做巨大子宫切除术时,MAH仍存在术中出血稍增加、手术后住院时间平均延长1.5 d的缺点。MAH伤口更小,疼痛更轻。本文显示MAH治疗增大的子宫的操作技术可以安全完成,不伴有任何器官损伤,手术时间更短。因此,在行巨大子宫切除术时,MAH可以作为一种备选的手术方法。 展开更多
关键词 小切口手术 经腹子宫切除术 腹腔镜子宫切除术 巨大子宫 手术路径
下载PDF
Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer 被引量:43
3
作者 Michael Hocke Ewald Schulze +2 位作者 Peter Gottschalk Theodor Topalidis Christoph F Dietrich 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第2期246-250,共5页
AIM: To evaluate the contrast-enhanced endosonography as a method of differentiating inflammation from pancreatic carcinoma based on perfusion characteristics of microvessels. METHODS: In 86 patients with suspected ... AIM: To evaluate the contrast-enhanced endosonography as a method of differentiating inflammation from pancreatic carcinoma based on perfusion characteristics of microvessels. METHODS: In 86 patients with suspected chronic pancreatitis (age: 62± 12 years; sex: f/m 38/48), pancreatic lesions were examined by conventional endo- scopic B-mode, power Doppler ultrasound and contrastenhanced power mode (Hitachi EUB 525, SonoVue, 2.4 mL, Bracco) using the following criteria for malignant lesions: no detectable vascularisation using conventional power Doppler scanning, irregular appearance of arterial vessels over a short distance using SonoVue contrastenhanced technique and no detectable venous vessels inside the lesion. A malignant lesion was assumed if all criteria were detectable [gold standard endoscopic ultrasound (EUS)-guided fine needle aspiration cytology, operation]. The criteria of chronic pancreatitis without neoplasia were defined as no detectable vascularisation before injection of SonoVue, regular appearance of vessels over a distance of at least 20 mm after injection of SonoVue and detection of arterial and venous vessels. RESULTS: The sensitivity and specifidty of conventional EUS were 73.2% and 83.3% respectively for pancreatic cancer. The sensitivity of contrast-enhanced EUS increased to 91.1% in 51 of 56 patients with malignant pancreatic lesion and the specificity increased to 93.3% in 28 of 30 patients with chronic inflammatory pancreatic disease.CONCLUSION: Contrast-enhanced endoscopic ultrasound improves the differentiation between chronic pancreatitis and pancreatic carcinoma. 展开更多
关键词 Endoscopic ultrasound Contrast enhancer Chronic pancreatitis Pancreatic cancer
下载PDF
Endoscopic ultrasonography-guided endoscopic treatment of pancreatic pseudocysts and walled-off necrosis:New technical developments 被引量:12
4
作者 Barbara Braden Christoph F Dietrich 《World Journal of Gastroenterology》 SCIE CAS 2014年第43期16191-16196,共6页
In the last decades,the treatment of pancreatic pseudocysts and necrosis occurring in the clinical context of acute and chronic pancreatitis has shifted towards minimally invasive endoscopic interventions.Surgical pro... In the last decades,the treatment of pancreatic pseudocysts and necrosis occurring in the clinical context of acute and chronic pancreatitis has shifted towards minimally invasive endoscopic interventions.Surgical procedures can be avoided in many cases by using endoscopically placed,Endoscopic ultrasonography-guided techniques and drainages.Endoscopic ultrasound enables the placement of transmural plastic and metal stents or nasocystic tubes for the drainage of peripancreatic fluid collections.The development of selfexpanding metal stents and exchange free delivering systems have simplified the drainage of pancreatic fluid collections.This review will discuss available therapeutic techniques and new developments. 展开更多
关键词 Pancreatic pseudocyst Walled-off necrosis Endoscopic ultrasonography-guided drainage Self-expanding metal stent Acute pancreatitis
下载PDF
在澳大利亚利用腹腔镜进行附件手术的现状和变化趋势
5
作者 Felix Wong Eric Lee +1 位作者 王珺 应小燕 《中国微创外科杂志》 CSCD 2011年第6期483-488,共6页
自从引入腹腔镜手术,普遍认为应用腹腔镜进行附件手术会取代开腹手术。然而事实证明,虽然腹腔镜手术开展了20多年,开腹附件手术仍未被淘汰。这份来自澳大利亚各州及地区关于附件手术病人的资料显示了在澳大利亚应用腹腔镜进行附件手术... 自从引入腹腔镜手术,普遍认为应用腹腔镜进行附件手术会取代开腹手术。然而事实证明,虽然腹腔镜手术开展了20多年,开腹附件手术仍未被淘汰。这份来自澳大利亚各州及地区关于附件手术病人的资料显示了在澳大利亚应用腹腔镜进行附件手术的变化趋势。同时还有一份来自悉尼利物浦医院病人的资料同样也说明了在附件手术中决定选择何种手术方式的影响因素。我们的研究认为,在所有附件手术中,应用腹腔镜进行手术已经增加到90%,然而大概还有10%的病人需要开腹手术。全国范围内附件手术在手术方式选择上的变化趋势受政府医疗保险政策变化的影响。利物浦医院的当地资料显示,不同个体在手术方式选择上的变化趋势与澳大利亚全国范围内附件手术方式变化趋势不同,是由于管理人员和资金的改变引起的。从病人利益角度考虑,一项对妇科医师问卷调查显示,下述因素是导致医师选择开腹手术的重要原因:术前怀疑肿瘤是恶性的;医生缺少腹腔镜技术的培训;急诊状况下。术前应用敏感性高和特异性好的肿瘤标志物改善附件恶性肿瘤术前诊断的准确性有利于更多病人进入腔镜组而不是开腹组,同时医师经过良好的训练和提高手术技术也可以在不久的将来促进腹腔镜手术的发展。 展开更多
关键词 附件手术 腹腔镜手术 开腹手术 趋势
下载PDF
Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries? 被引量:2
6
作者 Paolo Gontero Marco Oderda +6 位作者 Claudia Filippini Francesco Fontana Elisa Lazzarich Piero Stratta Ernesto Turello Alessandro Tizzani Bruno Frea 《Asian Journal of Andrology》 SCIE CAS CSCD 2012年第4期621-625,共5页
Reduced cavernosal arterial inflow has been hypothesized to be the likely cause of erectile dysfunction after kidney transplants in recipients revascularized through end-to-end anastomosis to the internal lilac artery... Reduced cavernosal arterial inflow has been hypothesized to be the likely cause of erectile dysfunction after kidney transplants in recipients revascularized through end-to-end anastomosis to the internal lilac artery, suggesting that end-to-side anastomosis at the external iliac artery is preferable. The aim of this study was to prospectively evaluate the effect of the use of the external iliac artery on erectile function, hormone profiles and penile blood flow by evaluating changes in penile colour Doppler ultrasound parameters in a consecutive series of 22 recipients before and after end-to-side external lilac artery transplantation. The mean International Index of Erectile Function-Erectile Function (IIEF-EF) domain score decreased significantly 3 months after transplant (18.09±6.33 vs. 22.50±7.09, P=O.01). The reduction in peak systolic velocity (PSV) was significant for the cavernous artery homolateral to the side of transplant (42.60±18.77 vs. 52.01±19.91, P=0.01). The mean postoperative end diastolic velocity (EDV) did not differ significantly from the preoperative value (P=0.74). No statistical differences were found in the serum levels of testosterone or prolactin. Kidney grafts anastomosed at the external lilac artery produced significant (P=0.01) reductions in arterial inflow at the homolateral cavernosal artery that remained above the normal threshold. Whether these haemodynamic changes can explain the worsening of postoperative erectile function remains to be proven. 展开更多
关键词 cavernosal arteries DOPPLER erectile dysfunction external iliac artery kidney transplant
下载PDF
瑞舒伐他汀对存在亚临床动脉粥样硬化的低危人群颈动脉内膜中层厚度进展的影响——METEOR试验 被引量:45
7
作者 John R. Crouse Ⅲ Joel S. Raichlen +6 位作者 Ward A. Riley Gregory W. Evans Mike K. Palmer Daniel H. O' Leary Diederick E. Grobbee Michiel L. Bots 李军(译) 《美国医学会杂志(中文版)》 2007年第4期208-216,共9页
背景:动脉粥样硬化往往在机体出现症状之前就已有所进展。目前,我们尚不清楚Framingham风险评分(Framinghaln risk score,FRS)较低的轻中度亚临床动脉粥样硬化中年人群是否能从治疗中获益。 目的:评价为期2年的他汀类药物治疗能... 背景:动脉粥样硬化往往在机体出现症状之前就已有所进展。目前,我们尚不清楚Framingham风险评分(Framinghaln risk score,FRS)较低的轻中度亚临床动脉粥样硬化中年人群是否能从治疗中获益。 目的:评价为期2年的他汀类药物治疗能否减缓颈动脉内膜中层厚度(carotid intimamedia thickness,CIMT)继续增厚或使粥样斑块消退。 设计、地点及参试者:“瑞舒伐他汀对内膜中层厚度影响的测评研究(Measuring Effects on Intima-Media Thickness:an Evaluation of Rosuvastatin,METEOR)”是2002年8月至2006年5月在美国及欧洲61个基层医疗中心开展的一项随机、双盲、安慰剂对照研究,共纳入984名参试者,有的参试者仅以年龄(平均年龄,57岁)为冠心病的危险因素,有的参试者10年内FRS低于10%、CIMT重庞增厚(1.2~3.5mm)、LDL胆固醇水平有所升高(平均值,154mg/dL)。 干预:参试者服用40mg瑞舒伐他汀或安慰剂。 主要观测指标:12个颈动脉位点最大CIMT的变化率(经B超检测);颈总动脉位点、颈动脉窦位点及颈内动脉位点最大CIMT的变化,颈总动脉位点平均CIMT的变化。仅在瑞舒伐他汀组中评估CIMT的消退情况。 结果:瑞舒伐他汀组参试者LDL胆固醇平均(SD)水平由基线时的155(24.1)mg/dL降至78(27.5)mg/dL,平均降低49%(与安慰剂组相比P〈0.001)。瑞舒伐他汀组12个颈动脉位点最大CIMT的变化值为-0.0014(95%CI,-0.0041~0.0014)mm/y,安慰剂组12个颈动脉位点最大CIMT的变化值为Q0131(95%CI,Q0087~Q0174)mm/y(P〈0.001)。瑞舒伐他汀组颈总动脉位点最大CIMT的变化值为-0.0038(95%CI,-0.0064~-0.0013)mm/y(P〈0.001),颈动脉窦位点最大CIMT的变化值为-0.0040(95%CI,-0.0090~0.0010)mm/y(P〈0.001),颈内动脉位点最大CIMT的变化值为0.0039(95%CI,-0.0009~0.0088)mm/y(P=0.02)。瑞舒伐他汀组颈总动脉位点平均CIMT的变化值为0.0004(95%CI,-0.0011~0.0019)mm/y(P〈0.001)。P值均为与安慰剂组相比。总的来说,瑞舒伐他汀具有良好的耐受性,很少引发严重的心血管不良事件(在2年内有6名参试者[0.86%]出现8起不良事件[1.1%])。 结论:对于FRS低于10%的亚临床动脉粥样硬化中年人群而言,瑞舒伐他汀能够在2年内显著降低最大CIMT的进展速率,与安慰剂相比差异具有统计学显著性。但是,瑞舒伐他汀无法诱导病变消退。今后,我们仍需开展大型远期试验来明确上述研究结果的临床意义. 展开更多
关键词 亚临床动脉粥样硬化 颈动脉内膜中层厚度 瑞舒伐他汀 低危人群 ROSUVASTATIN 试验 心血管不良事件 安慰剂对照
下载PDF
Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots:A Review
8
作者 Deepak Madhu Sanchit Sharma +1 位作者 Ashish Agarwal Anoop Saraya 《Journal of Clinical and Translational Hepatology》 SCIE 2021年第4期568-575,共8页
The ongoing coronavirus disease-2019(COVID-19)pandemic has necessitated special considerations in the management of diseases.The way presence of pre-existing diseases or treatment for it predisposes to,alters course o... The ongoing coronavirus disease-2019(COVID-19)pandemic has necessitated special considerations in the management of diseases.The way presence of pre-existing diseases or treatment for it predisposes to,alters course of,and changes the management of COVID-19,is of relevance and is being extensively studied.Autoimmune hepatitis(AIH)is unique in that it is an autoimmune disease mandating treatment with immunosuppressive drugs,as well as a liver disease with potential for varying degrees of underlying fibrosis.The use of immunosuppressive drugs could alter the risk of acquiring COVID-19,the clinical course and severity of COVID-19 and the degree of underlying liver fibrosis could alter the clinical outcomes of patients with COVID-19.In this review,we try to summarize key areas relevant in understanding and improving the clinical care of patients with AIH in the current pandemic.Special considerations required in the management of patients with AIH in COVID-19 hotspots have been outlined based on the current evidence. 展开更多
关键词 HEPATITIS AUTOIMMUNE Liver cirrhosis COVID-19 SARS-CoV-2 infection Immunosuppressive agents
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部